The roles of long non‑coding RNAs in renal cell carcinoma (Review)

  • Authors:
    • Zhengming Su
    • Jian Ao
    • Fengjin Zhao
    • Guibin Xu
    • Huihua Chen
    • Chen Gao
  • View Affiliations

  • Published online on: November 28, 2022     https://doi.org/10.3892/mco.2022.2600
  • Article Number: 4
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Long non‑coding RNAs (lncRNAs) are involved in the gene expression regulation and usually play important roles in various human cancers, including the renal cell carcinoma (RCC). Dysregulation of certain lncRNAs are associated with the prognosis of patients with RCC. In the present review, several recently studied lncRNAs were discussed and their critical roles in proliferation, migration, invasion, apoptosis and drug resistance of renal cancer cells were revealed. The research on lncRNAs further increases our understanding on the development and progression of RCC. It is suggested that lncRNAs can be used as biomarkers or therapeutic targets for diagnosis or treatment of renal cancer.

Related Articles

Journal Cover

January-2023
Volume 18 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Su Z, Ao J, Zhao F, Xu G, Chen H and Gao C: The roles of long non‑coding RNAs in renal cell carcinoma (Review). Mol Clin Oncol 18: 4, 2023
APA
Su, Z., Ao, J., Zhao, F., Xu, G., Chen, H., & Gao, C. (2023). The roles of long non‑coding RNAs in renal cell carcinoma (Review). Molecular and Clinical Oncology, 18, 4. https://doi.org/10.3892/mco.2022.2600
MLA
Su, Z., Ao, J., Zhao, F., Xu, G., Chen, H., Gao, C."The roles of long non‑coding RNAs in renal cell carcinoma (Review)". Molecular and Clinical Oncology 18.1 (2023): 4.
Chicago
Su, Z., Ao, J., Zhao, F., Xu, G., Chen, H., Gao, C."The roles of long non‑coding RNAs in renal cell carcinoma (Review)". Molecular and Clinical Oncology 18, no. 1 (2023): 4. https://doi.org/10.3892/mco.2022.2600